These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 9298352)
1. Comparison of four 'second generation' immunoassay systems to determine CA 125 in serum by using a graphical approach to method comparison analysis. Koper NP; Thomas CM; Massuger LF; Segers MF; Kiemeney LA; Verbeek AL Eur J Clin Chem Clin Biochem; 1997 Aug; 35(8):617-23. PubMed ID: 9298352 [TBL] [Abstract][Full Text] [Related]
2. Multicenter evaluation of the Elecsys CA 125 II assay. Hubl W; Chan DW; Van Ingen HE; Miyachi H; Molina R; Filella X; Pitzel L; Ruibal A; Rymer JC; Bagnard G; Domke I Anticancer Res; 1999; 19(4A):2727-33. PubMed ID: 10470230 [TBL] [Abstract][Full Text] [Related]
3. IMMULITE OM-MA assay: a useful diagnostic tool in patients with benign and malignant ovarian tumors. Gebauer G; Rieger M; Jäger W; Lang N Anticancer Res; 1999; 19(4A):2535-6. PubMed ID: 10470190 [TBL] [Abstract][Full Text] [Related]
4. Analytical and clinical performance of improved Abbott IMx CA 125 assay: comparison with Abbott CA 125 RIA. Thomas CM; Massuger LF; Segers MF; Schijf CP; Doesburg WH; Wobbes T Clin Chem; 1995 Feb; 41(2):211-6. PubMed ID: 7874773 [TBL] [Abstract][Full Text] [Related]
5. Clinical and technical evaluation of the ACS:OV serum assay and comparison with three other CA125-detecting assays. Davelaar EM; Schutter EM; von Mensdorff-Pouilly S; van Kamp GJ; Verstraeten RA; Kenemans P Ann Clin Biochem; 2003 Nov; 40(Pt 6):663-73. PubMed ID: 14629806 [TBL] [Abstract][Full Text] [Related]
6. Quantification of D-dimer using a new fully automated assay: its application for the diagnosis of deep vein thrombosis. Villa P; Ferrando F; Serra J; Faus H; Mira Y; Vayá A; Aznar J Haematologica; 2000 May; 85(5):520-4. PubMed ID: 10800170 [TBL] [Abstract][Full Text] [Related]
7. A multicentre evaluation of the CA 15-3 assay, CA 19-9 assay and CA 125 II assay on the Bayer Immuno 1 System. Römer M; Haeckel R; Brux B; Sinha P; Raiko I; Krieg M; Stark M; Seidel D; Hübner U; Schmitz G Eur J Clin Chem Clin Biochem; 1997 Aug; 35(8):637-44. PubMed ID: 9298356 [TBL] [Abstract][Full Text] [Related]
8. Significance of preoperative serum CA-125 levels in the prediction of lymph node metastasis in epithelial ovarian cancer. Kim HS; Park NH; Chung HH; Kim JW; Song YS; Kang SB Acta Obstet Gynecol Scand; 2008; 87(11):1136-42. PubMed ID: 18951217 [TBL] [Abstract][Full Text] [Related]
9. Afamin and apolipoprotein A-IV: novel protein markers for ovarian cancer. Dieplinger H; Ankerst DP; Burges A; Lenhard M; Lingenhel A; Fineder L; Buchner H; Stieber P Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1127-33. PubMed ID: 19336561 [TBL] [Abstract][Full Text] [Related]
10. [Prognostic value of early normalization of CA 125 during chemotherapy in stages III and IV ovarian tumors]. Ferrero JM; Largillier R; Ramaioli A; Heudier P; Teissier E; Namer M Bull Cancer; 1997 Jul; 84(7):722-8. PubMed ID: 9339198 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of a sensitive immunoluminometric assay for the determination of C-reactive protein (CRP) in serum and plasma and the establishment of reference ranges for different groups of subjects. Wood WG; Lüdemann J; Mitusch R; Heinrich J; Maass R; Frick U Clin Lab; 2000; 46(3-4):131-40. PubMed ID: 10791120 [TBL] [Abstract][Full Text] [Related]
12. Diagnostic markers for early detection of ovarian cancer. Visintin I; Feng Z; Longton G; Ward DC; Alvero AB; Lai Y; Tenthorey J; Leiser A; Flores-Saaib R; Yu H; Azori M; Rutherford T; Schwartz PE; Mor G Clin Cancer Res; 2008 Feb; 14(4):1065-72. PubMed ID: 18258665 [TBL] [Abstract][Full Text] [Related]
13. The "real-life" variability of CA-125 in ovarian cancer patients. Tso E; Elson P; Vanlente F; Markman M Gynecol Oncol; 2006 Oct; 103(1):141-4. PubMed ID: 16537090 [TBL] [Abstract][Full Text] [Related]
14. Calculation of the risk of ovarian cancer from serial CA-125 values for preclinical detection in postmenopausal women. Skates SJ; Menon U; MacDonald N; Rosenthal AN; Oram DH; Knapp RC; Jacobs IJ J Clin Oncol; 2003 May; 21(10 Suppl):206s-210s. PubMed ID: 12743136 [TBL] [Abstract][Full Text] [Related]
15. Urinary gonadotropin peptide (UGP) and serum CA 125 in gynaecologic practice, a clinical prospective study. Schutter EM; Mijatovic V; Kok A; Van Kamp GJ; Verstraeten R; Verheijen RH Anticancer Res; 1999; 19(6C):5551-7. PubMed ID: 10697615 [TBL] [Abstract][Full Text] [Related]
16. Comparison of commercially available serologic kits for the detection of celiac disease. Naiyer AJ; Hernandez L; Ciaccio EJ; Papadakis K; Manavalan JS; Bhagat G; Green PH J Clin Gastroenterol; 2009 Mar; 43(3):225-32. PubMed ID: 18724250 [TBL] [Abstract][Full Text] [Related]
17. Serum CA-125 in relation to adnexal dysplasia and cancer in women at hereditary high risk of ovarian cancer. Hermsen BB; von Mensdorff-Pouilly S; Berkhof J; van Diest PJ; Gille JJ; Menko FH; Blankenstein MA; Kenemans P; Verheijen RH J Clin Oncol; 2007 Apr; 25(11):1383-9. PubMed ID: 17416858 [TBL] [Abstract][Full Text] [Related]
18. The pretreatment plasma level and diagnostic utility of M-CSF in benign breast tumor and breast cancer patients. Ławicki S; Szmitkowski M; Wojtukiewicz M Clin Chim Acta; 2006 Sep; 371(1-2):112-6. PubMed ID: 16631152 [TBL] [Abstract][Full Text] [Related]
19. EIA versus RIA in detecting carcinoembryonic antigen level of patients with metastatic colorectal cancer. Wang WS; Lin JK; Lin TC; Chiou TJ; Liu JH; Yen CC; Chen WS; Jiang JK; Yang SH; Wang HS; Chen PM Hepatogastroenterology; 2004; 51(55):136-41. PubMed ID: 15011849 [TBL] [Abstract][Full Text] [Related]
20. Comparison of seven immunoassays for the quantification of CA 125 antigen in serum. Davelaar EM; van Kamp GJ; Verstraeten RA; Kenemans P Clin Chem; 1998 Jul; 44(7):1417-22. PubMed ID: 9665418 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]